10x Genomics, Inc.

TXG Nasdaq CIK: 0001770787

Company Information

Industry Laboratory Analytical Instruments
SIC Code 3826
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
Mailing Address 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
Phone (925) 401-7300
Fiscal Year End 1231
EIN 455614458

Financial Overview

FY2025

$245.04M
Total Liabilities
$805.74M
Stockholders' Equity
$-1.52
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report February 13, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 8, 2026 View on SEC
4 Insider stock transaction report January 7, 2026 View on SEC
4 Insider stock transaction report November 25, 2025 View on SEC
4 Insider stock transaction report November 25, 2025 View on SEC
4 Insider stock transaction report November 25, 2025 View on SEC
8-K Current report of material events November 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 13, 2025 View on SEC

Annual Reports

10-K February 13, 2026
  • Leading position in single-cell and spatial genomics with innovative platforms like Chromium and Visium.
  • Achieved $615 million revenue, a 15% increase, driven by strong consumable sales (70% of total revenue).
View Analysis

Related Companies

Companies in the same industry (SIC: 3826)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.